Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glycomimetics Inc (NQ: GLYC )

0.3826 -0.0243 (-5.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glycomimetics Inc

< Previous 1 2 3 4 5 6 7 Next >
GlycoMimetics Announces Its Addition to the Russell Microcap® Index
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics Announces U.S. Food and Drug Administration Clears Addition of Time-based Final Analysis to Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics to Participate in Upcoming Jefferies 2023 Healthcare Conference
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope... 
Via Talk Markets
GlycoMimetics: Q1 Earnings Insights
Via Benzinga
Earnings Preview For GlycoMimetics
Via Benzinga
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics to Report First Quarter 2023 Financial Results on May 3, 2023
From GlycoMimetics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022
From GlycoMimetics, Inc.
Via Business Wire
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million. 
Via Benzinga
GlycoMimetics to Report Fourth Quarter and 2022 Full Year Financial Results on March 29, 2023
From GlycoMimetics, Inc.
Via Business Wire
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of... 
Via Benzinga
GlycoMimetics to Participate in Upcoming Cowen 43rd Annual Health Care Conference
From GlycoMimetics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
$3M Bet On This Biotechnology Stock? Check Out These 3 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Pagaya Technologies To Rally Around Over 120%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Twilio Inc. (NYSE: TWLO) from $77 to $89. Keybanc analyst Thomas Blakey maintained an Overweight rating on the stock. Twilio shares gained 6.4% to close at $66.05... 
Via Benzinga
GlycoMimetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlycoMimetics, Inc.
Via Business Wire
Nasdaq Surges 90 Points; Credo Technology Group Shares Slide
U.S. stocks turned mostly higher toward the end of trading, with the Nasdaq Composite gaining around 90 points on Wednesday. The Dow traded down 0.01% to 34,085.88 while the NASDAQ rose 0.76% to... 
Via Benzinga
Gold Down 1%; Roblox Shares Spike Higher
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 100 points on Wednesday. The Dow traded down 0.34% to 33,974.46 while the NASDAQ rose 0.22% to 11,986.30. The... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL. 
Via Benzinga
Dow Dips 200 Points; US Retail Sales Rise 3%
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.61% to 33,880.45 while the NASDAQ fell... 
Via Benzinga
GlycoMimetics Announces Continuation of Phase 3 Study of E-selectin Antagonist Uproleselan in Relapsed/Refractory AML to Originally Planned Final Analysis Following Interim Analysis by Independent Data Monitoring Committee
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow
Dan Cohen and Scott Matusow discuss In this 1:11 audio the upcoming data sets for Glycomimetics. We talk about The Company's platform chemistry in depth, and give our predictions for success/failure of... 
Via Talk Markets
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From GlycoMimetics, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Dip
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
GlycoMimetics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones settled slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around... 
Via Benzinga
US Stocks Rise; Dow Gains 100 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday. 
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.